Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Trade Show

SoCalBio Announces Presenting Companies for 3rd Digital Health Conference

The Southern California Biomedical Council (SoCalBio) ? the voice and advocate for the bioscience and digital health industries in the Greater Los Angeles region -- today announced its final list of 12 companies selected to present at the 3rd Digital Health Conference (SoCalBioDH.com).

The conference, which will be held on Friday, December 13th at the historic Hotel Casa del Mar on the beach in Santa Monica, serves as a showcase for the latest advances in data mining and analytics to help diagnose and treat medical conditions.

In addition to keynote presentations and panel discussions, the conference will feature presentations by the following companies working to transform health data and analytics:

The above companies were screened and selected by members of SoCalBio's Innovation Catalyst Program, a unique network of senior bioscience and healthcare professionals who also provide presentation and business coaching for SoCalBio conferences presenters.

"This year's list of presenting companies is representative of the many innovative digital health ventures across the Greater Los Angeles region that are working to reimagine healthcare," said Peter Blaisdell, Ph.D., board member of Afecta Pharmaceuticals and chair of SoCalBio's Innovation Catalyst Program. "They offer a preview of the future of value-based healthcare, and we hope the conference provides them with opportunities to increase their visibility and access resources needed for success."

SoCalBio President and CEO Ahmed Enany added, "We welcome the 2019 presenters to be part of the growing SoCalBio family of companies working to drive change in healthcare delivery. They are helping cement the Los Angeles region's status as a leading center for health and wellness."

In addition to emerging company presentations, this year's SoCalBio Digital Health Conference will feature keynote sessions focused on the opportunities and challenges of integrating new technologies such as artificial intelligence and machine learning into the spectrum of care.

Distinguished speakers include:

The conference will also tap prominent L.A. region investors and business development professionals to examine the factors that drive funding and corporate partnerships in the digital health industry. Participants include:

SoCalBio thanks the following sponsors for their support:

About the SoCalBio Digital Health Conference

The SoCalBio Digital Health Conference is a showcase for digital innovations poised to disrupt the $3.7 trillion US healthcare system. It is also a forum for providers, payers, entrepreneurs and investors to share information on how digitization can help improve care while reducing costs. More information is available at http://www.socalbiodh.com.

About SoCalBio

SoCalBio is a nonprofit, member-supported trade association that promotes bioscience research, development, manufacturing, job creation and overall economic growth in the Greater Los Angeles region. The Council's programs help local firms gain access to capital, potential partners and business support services. SoCalBio also promotes technology transfer and workforce training, while informing policy makers and the public-at-large about the benefits of the LA region's life-science industry. More information about SoCalBio is available at www.socalbio.org.

These press releases may also interest you

at 16:34
ArisGlobal, the leading provider of life sciences software that automates core drug development functions for over 250 life sciences companies, has expanded its partnership with Soterius, Inc., adding LifeSphere® MultiVigilance and LifeSphere®...

at 16:30
The "Pharma Supply Chain & Security World 2020" conference has been added to ResearchAndMarkets.com's offering. Pharma Supply Chain & Security World 2020 will have Pharma industry experts sharing various challenges faced, new strategies, case studies...

at 16:20
PerkinElmer, Inc. , a global leader committed to innovating for a healthier world, today reported financial results for the fourth quarter and full year ended December 29, 2019. Fourth Quarter 2019 The Company reported GAAP earnings per share from...

at 16:20
Endo International plc  today announced that one of its operating companies, Par Pharmaceutical (Par), has begun shipping an authorized generic version of Allergan's Carafate® (sucralfate) oral suspension 1gm/10 mL. "Par is proud to partner with...

at 16:15
The "Ophthalmic Devices Market Global Forecast by Application, Products, Regions, Companies" report has been added to ResearchAndMarkets.com's offering. Global Ophthalmic Device Market is Projected to Reach More Than US$ 67 Billion by the End of 2026...

at 16:15
North America healthcare IT market size to grow at a 16.4% CAGRThe North America healthcare IT market size is projected to reach USD 239.9 billion by 2025 from USD 96.3 billion in 2019, at a CAGR of 16.4%. There is a growing inclination across the...

News published on 4 december 2019 at 19:10 and distributed by: